Skip to content

Members' voluntary liquidation NEWBRIDGE PHARMA LTD.

Exeter06011430-mvlDate: 03/08/2020Updated 04/10/2026, 03:40
More details available to registered users
Free access to practitioner details, reports and alerts

NEWBRIDGE PHARMA LTD. in Exeter (South West) entered members' voluntary liquidation, a solvent winding-up. Jonathan Lee Mitchell has been appointed as insolvency practitioner. The case reference is 06011430-mvl. The principal activity of NEWBRIDGE PHARMA LTD. is wholesale of pharmaceutical goods.

General information

NameNEWBRIDGE PHARMA LTD.
TownExeter (South West)
Company number06011430
Case no.06011430-mvl
StatusMembers' voluntary liquidation
Order date03/08/2020
Company typePrivate limited company
Incorporated on28/11/2006
Company statusdissolved
Dissolved on30/04/2023

Sector

GroupWholesale and retail trade
Primary codeWholesale of pharmaceutical goods (46460)

Offices and addresses

Registered office
26-28 Southernhay East
EX1 1NS Exeter

Directors

Directors are visible after free registrationRegister free

Notices

03/08/2020CompanyIssuedNotice
3605264
03/08/2020CompanyIssuedLiquidatorAppointment
3605153
03/08/2020Resolution
3605148

Insolvency practitioner

Jonathan Lee Mitchell
Address26-28 Southernhay East, EX1 1NS Exeter
Practitioner contact details are visible after free registrationRegister free

InsolvencyIndex draws on public sources and makes every effort to keep the content of this page up to date and complete. Despite that care, the content may be incomplete or inaccurate. InsolvencyIndex provides the content of this website "as is", without any warranty as to its soundness, fitness for a particular purpose or otherwise. InsolvencyIndex accepts no liability for loss arising from, or in any way connected with, the use of this website or any inability to consult it. Save as set out in this disclaimer, InsolvencyIndex is not responsible for third-party files linked from this page; linking does not imply any endorsement of those files. Notices reproduced here are extracts from official publications; if you believe an entry is inaccurate, please contact us and we will correct it.